PIPERACILLIN (PIPERACILLIN SODIUM) — all Canadian products
65 DINs
28 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is PIPERACILLIN (PIPERACILLIN SODIUM), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02330547 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 12 G; TAZOBACTAM (TAZOBACTAM SODIUM) 1.5 G | Marketed | |
| 02362627 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | STERIMAX INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3.000 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Marketed | |
| 02362635 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | STERIMAX INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4.0 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Marketed | |
| 02299658 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Marketed | |
| 02377748 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | STERIMAX INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 12 G; TAZOBACTAM (TAZOBACTAM SODIUM) 1.5 G | Marketed | |
| 02305623 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | MARCAN PHARMACEUTICALS INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Approved | |
| 02305631 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | MARCAN PHARMACEUTICALS INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Approved | |
| 02305658 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | MARCAN PHARMACEUTICALS INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Approved | |
| 02550407 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 36 G; TAZOBACTAM (TAZOBACTAM SODIUM) 4.5 G | Approved | |
| 02550393 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 12 G; TAZOBACTAM (TAZOBACTAM SODIUM) 1.5 G | Approved | |
| 02549093 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | AURO PHARMA INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 36 G; TAZOBACTAM (TAZOBACTAM SODIUM) 4.5 G | Approved | |
| 02362619 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | STERIMAX INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2.00 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Marketed | |
| 02549085 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | AURO PHARMA INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 12 G; TAZOBACTAM (TAZOBACTAM SODIUM) 1.5 G | Approved | |
| 02528711 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Marketed | |
| 02528703 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Marketed | |
| 02528673 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Marketed | |
| 02521539 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 36 G; TAZOBACTAM (TAZOBACTAM SODIUM) 4.5 G | Marketed | |
| 02439131 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | STERIMAX INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 36 G; TAZOBACTAM (TAZOBACTAM SODIUM) 4.5 G | Marketed | |
| 02402084 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | AURO PHARMA INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Marketed | |
| 02402076 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | AURO PHARMA INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Marketed | |
| 02402068 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | AURO PHARMA INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Marketed | |
| 02299623 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Marketed | |
| 02299631 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Marketed | |
| 02452596 | VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION | VPI PHARMACEUTICALS INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 36 G; TAZOBACTAM (TAZOBACTAM SODIUM) 4.5 G | Approved | |
| 02452553 | VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION | VPI PHARMACEUTICALS INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Approved | |
| 02452545 | VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION | VPI PHARMACEUTICALS INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Approved | |
| 02452561 | VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION | VPI PHARMACEUTICALS INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Approved | |
| 02452588 | VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION | VPI PHARMACEUTICALS INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 12 G; TAZOBACTAM (TAZOBACTAM SODIUM) 1.5 G | Approved | |
| 02420430 | JAMP-PIP/TAZ | JAMP PHARMA CORPORATION | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Cancelled Post Market | |
| 02370166 | PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Cancelled Post Market | |
| 02370158 | PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Cancelled Post Market | |
| 02370174 | PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Cancelled Post Market | |
| 02391538 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | MYLAN PHARMACEUTICALS ULC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Cancelled Post Market | |
| 02308444 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | APOTEX INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Dormant | |
| 02308452 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | APOTEX INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3.0 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Dormant | |
| 02308460 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | APOTEX INC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4.0 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Dormant | |
| 02391511 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | MYLAN PHARMACEUTICALS ULC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Cancelled Post Market | |
| 02391546 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | MYLAN PHARMACEUTICALS ULC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.50 G | Cancelled Post Market | |
| 02401312 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Cancelled Post Market | |
| 02401320 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Cancelled Post Market | |
| 02401339 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Cancelled Post Market | |
| 02465825 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 12 G; TAZOBACTAM (TAZOBACTAM SODIUM) 1.5 G | Cancelled Pre Market | |
| 02465833 | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 36 G; TAZOBACTAM (TAZOBACTAM SODIUM) 4.5 G | Cancelled Post Market | |
| 02246641 | PIPERACILLIN FOR INJECTION | HOSPIRA HEALTHCARE ULC | Powder For Solution | Intravenous; Intramuscular | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G | Cancelled Post Market | |
| 02246640 | PIPERACILLIN FOR INJECTION | HOSPIRA HEALTHCARE ULC | Powder For Solution | Intravenous; Intramuscular | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G | Cancelled Post Market | |
| 02248941 | PIPERACILLIN FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | Intramuscular; Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G | Cancelled Post Market | |
| 02248940 | PIPERACILLIN FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous; Intramuscular | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G | Cancelled Post Market | |
| 02248939 | PIPERACILLIN FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | Intravenous; Intramuscular | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G | Cancelled Post Market | |
| 02246642 | PIPERACILLIN FOR INJECTION | HOSPIRA HEALTHCARE ULC | Powder For Solution | Intramuscular; Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G | Cancelled Post Market | |
| 02305615 | PIPERACILLIN/TAZOBACTAM FOR INJECTION | PHARMA STRIDES CANADA CORPORATION | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.5 G | Cancelled Post Market | |
| 02305593 | PIPERACILLIN/TAZOBACTAM FOR INJECTION | PHARMA STRIDES CANADA CORPORATION | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.25 G | Cancelled Post Market | |
| 02305607 | PIPERACILLIN/TAZOBACTAM FOR INJECTION | PHARMA STRIDES CANADA CORPORATION | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 0.375 G | Cancelled Post Market | |
| 00564974 | PIPRACIL INJ 2GM/VIAL | LEDERLE CYANAMID CANADA INC. | Powder For Solution | Intravenous; Intramuscular | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G | Cancelled Post Market | |
| 00564982 | PIPRACIL INJ 3GM/VIAL | LEDERLE CYANAMID CANADA INC. | Powder For Solution | Intramuscular; Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G | Cancelled Post Market | |
| 00564990 | PIPRACIL INJ 4GM/VIAL | LEDERLE CYANAMID CANADA INC. | Powder For Solution | Intravenous; Intramuscular | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G | Cancelled Post Market | |
| 00857548 | PIPRACIL PHARMACY BULK 40GM/VIAL | CYANAMID CANADA INC. | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 40 G | Cancelled Post Market | |
| 02173697 | PIPRACIL PHARMACY BULK VIAL-PWS IV 40G/VIAL | WYETH-AYERST CANADA INC. | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 40 G | Cancelled Post Market | |
| 02173441 | PIPRACIL-PWS IM IV 4G/VIAL | WYETH CANADA | Powder For Solution | Intravenous; Intramuscular | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G | Cancelled Post Market | |
| 02173425 | PIPRACIL-PWS IV IM 2G/VIAL | WYETH CANADA | Powder For Solution | Intravenous; Intramuscular | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G | Cancelled Post Market | |
| 02173433 | PIPRACIL-PWS IV IM 3G/VIAL | WYETH CANADA | Powder For Solution | Intramuscular; Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G | Cancelled Post Market | |
| 02170809 | TAZOCIN | PFIZER CANADA ULC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 500 MG | Cancelled Post Market | |
| 02170795 | TAZOCIN | PFIZER CANADA ULC | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 375 MG | Cancelled Post Market | |
| 02083590 | TAZOCIN PWS IV 2G PIPERACILLIN-.25G TAZOBAC. | LEDERLE CYANAMID CANADA INC. | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 2 G; TAZOBACTAM (TAZOBACTAM SODIUM) 250 MG | Cancelled Post Market | |
| 02083604 | TAZOCIN PWS IV 3G PIPERACILLIN-.375G TAZOBAC | LEDERLE CYANAMID CANADA INC. | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 3 G; TAZOBACTAM (TAZOBACTAM SODIUM) 375 MG | Cancelled Post Market | |
| 02083612 | TAZOCIN PWS IV 4G PIPERACILLIN-.5G TAZOBAC. | LEDERLE CYANAMID CANADA INC. | Powder For Solution | Intravenous | PIPERACILLIN (PIPERACILLIN SODIUM) 4 G; TAZOBACTAM (TAZOBACTAM SODIUM) 500 MG | Cancelled Post Market |
Browse other molecules: